results of the CARiLLOn Mitral Annuloplasty Device european Union study
- schofer, J. et al. Percutaneous mitral annuloplasty for functional mitral regurgitation
- Circulation 120, 326–333
whereas patients in the control group did not. By contrast, none of these trials demonstrated an improvement in functional capacity associated with Crt after 6 months. However, the reverse trial showed that patients receiving active Crt had a significant 53% reduction in the relative risk of first hospitalization for heart failure (Hr 0.47, P = 0.003). this benefit was not evident in patients with a Qrs duration of <152 ms.